Nov 08, 2023 / 05:00PM GMT
Trung Chuong Huynh - UBS Investment Bank, Research Division - Analyst
Okay. We're at the top of the hour now. Hi, everyone. My name is Trung Huynh. I'm the U.S. pharma analyst here at UBS. It's my pleasure today to present at Merck, and we have Jannie Oosthuizen, hopefully, I've not destroyed that pronunciation, President of Human Health in the U.S. at Merck. Thanks for your time.
So for everyone -- if anyone wants to ask a question, just stick your hand up and I'll try and get to you. Also, if you have the app downloaded, you can send me your questions through the app, and I can attempt to ask those questions. But yes, let's begin. So before we start, Jannie, how about can you give us a bit of background about yourself, an introduction to yourself? And perhaps give us a recap of your highlights from 3Q results.
Johannes J. Oosthuizen - Merck & Co., Inc. - Senior VP & President Merck U.S. Human Health
Perfect. Well, thank you, Trung. Thanks for having us. So Jannie Oosthuizen. I've been Merck for the last 9 years. Prior to Merck, I spent about
Merck & Co Inc at UBS BioPharma Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers